Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084962A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084952A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084949A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084939A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084930A1 Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084610A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/16/2003WO2003084562A1 Chemokines mutants having improved oral bioavailability
10/16/2003WO2003084558A1 Improved kavalactone profile
10/16/2003WO2003084556A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084542A1 Neurotrophic factor production accelerator
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084521A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003WO2003084520A2 Pharmaceutical preparation containing oxycodone and naloxone
10/16/2003WO2003084514A1 Controlled release pharmaceutical compositions of carbidopa and levodopa
10/16/2003WO2003084504A2 Matrix for sustained, invariant and independent release of active compounds
10/16/2003WO2003084482A2 Antidepressants and their analogues as long-acting local anesthetics and analgesics
10/16/2003WO2003084464A2 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
10/16/2003WO2003066030A3 Pharmaceutical tablet
10/16/2003WO2003062405A3 Method for inducing differentiation of embryonic stem cells
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003053922A3 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
10/16/2003WO2003051393A3 Enzymatic cleavable reagents for specific delivery to disease sites
10/16/2003WO2003051313A3 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
10/16/2003WO2003048164A3 Adenosine a2a receptor antagonists
10/16/2003WO2003039575A3 Use of reelin, gas6, and protein s in the treatment of neural disorders
10/16/2003WO2003039555A3 Agents for treating lesions of the nervous system
10/16/2003WO2003039469A3 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
10/16/2003WO2003039231A3 Compounds and methods for treating transplant rejection
10/16/2003WO2003037159A3 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003032969B1 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
10/16/2003WO2003026743A3 Opioid formulations having reduced potential for abuse
10/16/2003WO2003024993A3 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
10/16/2003WO2003023034A3 Regulation of human tau-tubulin kinase
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/16/2003WO2003011828A3 3-pyridylether rerivatives and their use as analgesics
10/16/2003WO2003011314A3 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2003007802A9 Pharmaceutical combinations of oxycodone and naloxone
10/16/2003WO2003005968A3 Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa
10/16/2003WO2003005036A3 Epf receptor assays, compounds and therapeutic compositions
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002100382A3 Controlled release dosage forms using acrylic polymer, and process for making the same
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002064134A3 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies
10/16/2003WO2002036151A3 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
10/16/2003WO2002036118A3 Heterocyclic derivatives useful as pharmaceutical agents
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195261 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195235 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
10/16/2003US20030195234 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195216 Octahydro-2H-pyrido[1,2-a] pyrazine compounds
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195210 An enzyme inhibitors of cyclic guanosine 3',5'-monophophate-metabolizing phosphodiesterases; treating cardiovascular disorders, brian disorders, Alzheimer's disease, urogenital or sexual disorders
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195198 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195181 Laulimalide derivatives
10/16/2003US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates
10/16/2003US20030195177 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
10/16/2003US20030195169 Such as (S)-phosphoric acid mono-(3-(5-chloro-2-methoxy-phenyl)-3-fluoro-2-oxso-6-trifluoromethyl-2,3 -dihydro-indol-1-ylmethyl)ester; for modulation of large-conductance calcium-activated potassium (BK) channels
1 ... 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 ... 1833